May 28, 2025 a 07:43 am
ELV: Fundamental Ratio Analysis - Elevance Health Inc.
Elevance Health Inc. has shown consistent growth in the healthcare sector with a robust portfolio covering medical, digital, pharmacy, and clinical solutions. Despite mild fluctuations in certain financial metrics, the overall outlook remains positive given its market position and comprehensive service offerings to approximately 118 million people globally.
Fundamental Rating
The following table summarizes Elevance Health Inc.'s fundamental scores across key financial metrics.
| Category | Score | Visualization |
|---|---|---|
| Overall | 3 | |
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
Historical Rating
An evaluation of historical financial scores shows how Elevance Health Inc. has performed over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-05-23 | 3 | 5 | 4 | 4 | 1 | 2 | 2 |
Analyst Price Targets
Market analysts have provided the following price targets for Elevance Health Inc.
| High | Low | Median | Consensus |
|---|---|---|---|
| $465 | $465 | $465 | $465 |
Analyst Sentiment
The following table demonstrates current analyst recommendations for Elevance Health Inc.
| Recommendation | Number | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 27 | |
| Hold | 8 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Elevance Health Inc. is well-positioned in the healthcare sector with a strong focus on comprehensive healthcare solutions. Its financial metrics show mixed performance; however, its strategic initiatives and broad market reach offer significant growth opportunities. Analyst sentiment reflects a positive outlook with a consensus recommendation to Buy. Potential risks include market saturation and regulatory changes in the healthcare industry.